AbbVie Inc. (ABBV) vs Space Exploration Technologies Corp. Class A Common Stock (SPCX)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Space Exploration Technologies Corp., known as SpaceX, is an aerospace and satellite communications company founded by Elon Musk. The company designs, manufactures and launches reusable rockets and spacecraft, including the Falcon launch family, Dragon spacecraft and the Starship system under development. SpaceX also operates Starlink, a low Earth orbit satellite broadband network serving consumers, businesses, governments and mobility markets. Its business model combines launch services, satellite internet, defense and civil space contracts, and longer-term ambitions around fully reusable heavy-lift space transportation.